Ceftazidime does not enhance cyclosporin-a nephrotoxicity in febrile bone marrow transplantation patients
β Scribed by Verhagen, C. ;Pauw, B. E. ;Witte, T. ;Holdrinet, R. S. G. ;Janssen, J. T. P. ;Williams, K. J.
- Publisher
- Springer-Verlag
- Year
- 1986
- Weight
- 468 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of cyclosporin and prednisone on plasma lipid and lipoprotein levels were studied in 20 allogeneic bone-marrow transplantation patients receiving cyclosporin plus prednisone therapy, and in 14 allogeneic patients treated only with cyclosporin during 100 days. Eighteen autologous bone-mar
## Purpose: Our aim was to assess the feasibility of bone marrow transplantation (bmt) in patients with acute leukemia who have had prior documented invasive fungal infection within 5 months pretransplant treated aggressively with systemic amphoteric in b and, when applicable, surgical resection of
Background. The records and initial bone marrow studies of 106 patients with newly diagnosed acute myelogenous leukemia (AML) were analyzed retrospectively to determine whether bone marrow dysplasia was predictive of a previous myelodysplastic disorder or correlated with remission rate and survival.